Literature DB >> 12730778

Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN.

M R Sowers1, G A Greendale, I Bondarenko, J S Finkelstein, J A Cauley, R M Neer, B Ettinger.   

Abstract

We tested the hypothesis that higher serum osteocalcin and urinary N-telopeptide of type I collagen (NTx) concentrations would be found in women with increasing cycle irregularity or increased follicle stimulating hormone concentrations. We studied 2,375 pre- and early perimenopausal women from the Study of Women's Health Across the Nation (SWAN), aged 42-52 years, who self-identified their race/ethnic origin as African-American (28.3%), Caucasian (49.4%), Japanese (10.5%) or Chinese (11.8%). Outcome measures were serum osteocalcin, a measure of bone formation, and NTx, a measure of bone resorption. The explanatory variables were menopausal status, based on self-reported regularity of menstrual bleeding, and circulating endogenous hormone concentrations including estradiol (E(2)), testosterone (T), sex hormone binding globulin (SHBG) and follicle stimulating hormone (FSH) concentrations. Additionally, we evaluated the association of the bone turnover markers with the Free Androgen Index (FAI) and the Free Estradiol Index (FEI), ratios of total testosterone and estradiol concentrations to SHBG, respectively. Higher FSH concentrations were associated with higher NTx concentrations ( beta=0.003, partial r2=2.1%, p<0.0001), both before and after adjusting for other covariates (total explained variability of 9%). Higher FSH concentrations were also associated with higher osteocalcin concentrations ( beta=-0.216, partial r2=4.1%, p<0.0001, total explained variability of 15.4%). There were no significant associations of the bone turnover markers with other endogenous hormones, following adjustment for covariates. Mean osteocalcin and NTx values were not significantly different in premenopausal women compared to early perimenopausal women. In these pre- and early perimenopausal women, higher FSH concentrations, but not other serum reproductive hormone concentrations, are positively associated with greater bone turnover prior to the last menstrual period.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730778     DOI: 10.1007/s00198-002-1329-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

1.  Change in bone mass immediately before menopause.

Authors:  R R Recker; J M Lappe; K M Davies; D B Kimmel
Journal:  J Bone Miner Res       Date:  1992-08       Impact factor: 6.741

2.  Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills.

Authors:  R B Mazess; H S Barden
Journal:  Am J Clin Nutr       Date:  1991-01       Impact factor: 7.045

3.  Rates of change in spinal bone density among Japanese women.

Authors:  S Fujiwara; M Fukunaga; T Nakamura; J T Chen; M Shiraki; T Hashimoto; K Yoh; T Nakamura; H Mizunuma; T Tomomitsu; F Kasagi; N Masunari; H Orimo
Journal:  Calcif Tissue Int       Date:  1998-09       Impact factor: 4.333

4.  Age and menopause-related changes in indices of bone turnover.

Authors:  P J Kelly; N A Pocock; P N Sambrook; J A Eisman
Journal:  J Clin Endocrinol Metab       Date:  1989-12       Impact factor: 5.958

5.  Changes in biochemical markers of osteoblastic activity during the menstrual cycle.

Authors:  H K Nielsen; K Brixen; R Bouillon; L Mosekilde
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

6.  Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women.

Authors:  C Slemenda; C Longcope; M Peacock; S Hui; C C Johnston
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

7.  Premenopausal and postmenopausal changes in bone mineral density of the proximal femur measured by dual-energy X-ray absorptiometry.

Authors:  P Ravn; M L Hetland; K Overgaard; C Christiansen
Journal:  J Bone Miner Res       Date:  1994-12       Impact factor: 6.741

8.  The short-term effects of conjugated estrogen on bone turnover in older women.

Authors:  K M Prestwood; C C Pilbeam; J A Burleson; F N Woodiel; P D Delmas; L J Deftos; L G Raisz
Journal:  J Clin Endocrinol Metab       Date:  1994-08       Impact factor: 5.958

9.  Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey.

Authors:  L Forsén; H E Meyer; K Midthjell; T H Edna
Journal:  Diabetologia       Date:  1999-08       Impact factor: 10.122

10.  Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study.

Authors:  C Hassager; A Colwell; A M Assiri; R Eastell; R G Russell; C Christiansen
Journal:  Clin Endocrinol (Oxf)       Date:  1992-07       Impact factor: 3.478

View more
  53 in total

1.  Further evidence that FSH causes bone loss independently of low estrogen.

Authors:  Jameel Iqbal; Harry C Blair; Alberta Zallone; Li Sun; Mone Zaidi
Journal:  Endocrine       Date:  2012-02-21       Impact factor: 3.633

Review 2.  The role of FSH and TSH in bone loss and its clinical relevance.

Authors:  Manasi Agrawal; Guangyu Zhu; Li Sun; Mone Zaidi; Jameel Iqbal
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

Review 3.  Reproductive hormones and bone.

Authors:  Kristy M Nicks; Tristan W Fowler; Dana Gaddy
Journal:  Curr Osteoporos Rep       Date:  2010-06       Impact factor: 5.096

4.  Further evidence for direct pro-resorptive actions of FSH.

Authors:  Li Sun; Zhiyuan Zhang; Ling-Ling Zhu; Yuanzhen Peng; Xuan Liu; Jianhua Li; Manasi Agrawal; Lisa J Robinson; Jameel Iqbal; Harry C Blair; Mone Zaidi
Journal:  Biochem Biophys Res Commun       Date:  2010-02-19       Impact factor: 3.575

Review 5.  Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss.

Authors:  Mone Zaidi; Charles H Turner; Ernesto Canalis; Roberto Pacifici; Li Sun; Jameel Iqbal; X Edward Guo; Stuart Silverman; Solomon Epstein; Clifford J Rosen
Journal:  Curr Osteoporos Rep       Date:  2009-12       Impact factor: 5.096

6.  Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women.

Authors:  X-Y Wu; X-P Wu; H Xie; H Zhang; Y-Q Peng; L-Q Yuan; X Su; X-H Luo; E-Y Liao
Journal:  Osteoporos Int       Date:  2009-06-27       Impact factor: 4.507

Review 7.  Actions of pituitary hormones beyond traditional targets.

Authors:  Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen
Journal:  J Endocrinol       Date:  2018-03-19       Impact factor: 4.286

8.  New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition.

Authors:  Mone Zaidi; Harry C Blair; Jameel Iqbal; Terry F Davies; Ling Ling Zhu; Alberta Zallone; Li Sun
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

Review 9.  From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis.

Authors:  Stavros C Manolagas
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

10.  Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.

Authors:  Ling-Ling Zhu; Harry Blair; Jay Cao; Tony Yuen; Rauf Latif; Lida Guo; Irina L Tourkova; Jianhua Li; Terry F Davies; Li Sun; Zhuan Bian; Clifford Rosen; Alberta Zallone; Maria I New; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.